Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
1 non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
1 non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
-
1061
The SO-coupling-energy function <em>H<sub>s</sub></em> of δ<sub>1</sub> and δ<sub>−1</sub> with η = 0.0096 and κ = 2.0
Published 2013“…</strong> The SO-coupling-energy function <em>H<sub>s</sub></em> of δ<sub>1</sub> and δ<sub>−1</sub> with η = 0.0096 and κ = 2.0. …”
-
1062
-
1063
-
1064
-
1065
-
1066
Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer
Published 2018“…We screened for CHD 9 expression using immunohistochemical analysis in 87 surgical CRC specimens and found that the expression was upregulated in 81.5% of the cases, while 7.4% were decreased; in the remaining 11.1% of the cases, levels were not altered. …”
-
1067
-
1068
Mutant channel with deletion of the S10 region has decreased surface expression in a stable HEK293 cell line.
Published 2011“…Surface to total ratios were obtained by integration of the histograms. There is a 40% decrease in surface protein expression for the HSloΔS10 mutant determined by the surface to total HSlo ratio (+/− SEM, p = 0.032 in two sample t-test .n = 5).…”
-
1069
-
1070
-
1071
Significant decrease of SMAD4 protein in DBA iPSCs.
Published 2015“…A) Slight decrease of mRNA level of <i>SMAD4</i> in the DBA iPSCs with <i>RPS19</i> or <i>RPL5</i> mutations. …”
-
1072
Data_Sheet_1_T Cell Dysregulation in Non-silicotic Silica Exposed Workers: A Step Toward Immune Tolerance Breakdown.pdf
Published 2019“…Especially, among workers exposed more than 10 years, antinuclear antibodies and ANCA were detected in 44 and 22% among them, as compared to 5 and 2.5% in HC, respectively.</p><p>Conclusion: This work shows that CS exposure is associated with a decrease of Tregs frequency, an increase of T cell activation status, and a tolerance breakdown against auto-antigens. …”
-
1073
Image8_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…</p><p>Conclusion: PHLDA1 is a key regulator in the tumorigenesis and progression of Ewing sarcoma. …”
-
1074
Image10_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…</p><p>Conclusion: PHLDA1 is a key regulator in the tumorigenesis and progression of Ewing sarcoma. …”
-
1075
Image9_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…</p><p>Conclusion: PHLDA1 is a key regulator in the tumorigenesis and progression of Ewing sarcoma. …”
-
1076
Image12_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…</p><p>Conclusion: PHLDA1 is a key regulator in the tumorigenesis and progression of Ewing sarcoma. …”
-
1077
Image4_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…</p><p>Conclusion: PHLDA1 is a key regulator in the tumorigenesis and progression of Ewing sarcoma. …”
-
1078
Image7_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…</p><p>Conclusion: PHLDA1 is a key regulator in the tumorigenesis and progression of Ewing sarcoma. …”
-
1079
Image6_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…</p><p>Conclusion: PHLDA1 is a key regulator in the tumorigenesis and progression of Ewing sarcoma. …”
-
1080
Image2_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…</p><p>Conclusion: PHLDA1 is a key regulator in the tumorigenesis and progression of Ewing sarcoma. …”